Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
10 May 2024
// CONTRACT PHARMA
https://www.contractpharma.com/contents/view_breaking-news/2024-05-10/mabxience-names-new-chief-executive-officer/?widget=listSection
09 May 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mabxience-appoints-jurgen-van-broeck-as-new-ceo-302141331.html
16 Apr 2024
// Catherine Eckford EUROPEAN PHARMACEUTICAL REVIEW
https://www.europeanpharmaceuticalreview.com/news/226663/teva-enters-into-oncology-biosimilar-licensing-agreement/
04 Apr 2024
// BUSINESSWIRE
04 Apr 2024
// Fraiser Kansteiner FIERCE PHARMA
https://www.fiercepharma.com/pharma/teva-forging-ahead-pivot-growth-campaign-inks-biosimilar-licensing-deal-spains-mabxience
05 Feb 2024
// PRESS RELEASE
https://mabxience.com/mabxience-and-biosidus-sign-cdmo-agreement-for-the-manufacture-of-agalsidase-beta-for-the-treatment-of-fabry-disease/
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?